Perrigo | PRGO - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 5.57B 2.9B 2026-03
Abbott USD 2.39B 27M 2026-03
Bayer EUR -3.37B 2.21B 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Dr.Reddys Laboratories INR 4.58B 11.09B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
J&J USD 7.82B 2.86B 2026-03
Merck USD 3.42B 3.32B 2025-12
Nestle CHF 7.24B 1.1B 2024-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 61.81M 7.32M 2025-12
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zoetis USD 761M 126M 2025-12